Prospective randomised phase II study of gemcitabine at standard or fixed dose rate schedule in unresectable hepatocellular carcinomaZheng‐Hui Guan, M. Lehnert, S Maoleekoonpairoj et al.|British Journal of Cancer|2003Cited by 56